Patient specific Contrast Enhancement timing in Run-Off CTA Study

Patient specific Contrast Enhancement timing in Run-Off CTA Study - PACE-ROCS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030190

Enrollment

Registered

2023-01-31

Start date

2023-02-10

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I79

Interventions

Group 1: If stenosis of the iliac-legal stromal pathway is clinically suspected, CT imaging with contrast is performed. Patients in the prospective arm will be studied with delayed KM administration.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical suspicion of stenosis of the iliac-legal stromal pathway

Exclusion criteria

Exclusion criteria: - Contraindication to undergoing a computed tomography scan - Refusal to participate in the study - Age-adjusted normal serum creatinine or creatinine clearance > 30 ml / min / 1.73 m2 as a contraindication for safe contrast administration

Design outcomes

Primary

Measure	Time frame
Quality of contrast of the pelvic-legal stromal pathway (1/2/3/4/5)	—

Secondary

Measure	Time frame
Rate of nondiagnostic examinations, assessability of stenoses	—

Countries

Germany

Contacts

Public ContactBastian Sabel

LMU München Klinik und Poliklinik für Radiologie

Bastian.Sabel@med.uni-muenchen.de+49 89/4400-76642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026